BioSpace News Archive

Biotech Bay

Annexon Biosciences to Present at the Bank of America 2024 Health Care Conference

Annexon, Inc. announced that Douglas Love, president and chief executive officer, will present at the Bank of America Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT.

May 9, 2024
·
1 min read
Business

PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights

PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

May 9, 2024
·
8 min read
Biotech Beach

Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis

Bionano Genomics, Inc. announced significant upgrades to its suite of computational tools for comprehensive cancer analysis.

May 9, 2024
·
7 min read
Biotech Beach

ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones

ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, provided an update on various corporate milestones.

May 9, 2024
·
9 min read
Business

ACELYRIN, INC. Announces Leadership Transition - May 09, 2024

ACELYRIN, INC. announced that ACELYRIN’s founder Shao-Lee Lin, M.D., Ph.D. has stepped down as Chief Executive Officer and that Mina Kim, chief legal and administrative officer at ACELYRIN, has been appointed Chief Executive Officer and to the company’s Board of Directors.

May 9, 2024
·
9 min read
Biotech Beach

AEON Biopharma Provides Update on Development Pipeline

AEON Biopharma, Inc. provided an update on the status of its late-stage clinical pipeline for ABP-450 that targets multiple indications.

May 9, 2024
·
5 min read
Business

NEXGEL to Report First Quarter 2024 Financial Results on May 13th

NEXGEL, Inc. today announced it will report its financial results for the first quarter 2024, after the market closes on May 13, 2024.

May 9, 2024
·
1 min read
Policy

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

Terumo Blood and Cell Technologies, a medical technology company, recently received U.S. Food and Drug Administration 510 clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram.

May 9, 2024
·
4 min read
Business

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2024 and provided a corporate update.

May 9, 2024
·
10 min read
Biotech Bay

Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System

Pulse Biosciences, Inc. today announced the first procedure with the CellFX nsPFA Percutaneous Electrode System in the United States has been completed.

May 9, 2024
·
6 min read